knowledge -WSS

knowledge

author：explore 2025-09-29 01:37:33 - browse：39

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Hearing on Medicare drug price negotiation gets unusually heated

Wikipedia

WSS

Lasker Awards 2023: Winners in biomedical research

Lasker Awards 2023: Winners in biomedical research

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Lasker Awards 2023: Winners in biomedical research

Emergency workers more likely to restrain Black patients: study

Thermo Fisher plant for manufacturing gene therapies to expand

focus

knowledge

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Biotech stock slump in 2023: awaiting the turnaround

After affirmative action ruling, medical educators look to 'holistic review'

Why are Kaiser Permanente staff considering a strike?

United colonoscopy coverage change 'may cost lives,' doctors say

Senators: Long

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Thermo Fisher plant for manufacturing gene therapies to expand

Cancer drug shortages should be causing more outrage

Hearing on Medicare drug price negotiation gets unusually heated

leisure time

Emergency workers more likely to restrain Black patients: study

Why are Kaiser Permanente staff considering a strike?

Experts study whether long Covid risk adds up with each reinfection

Medical student insurance fails on mental health care coverage

CommonSpirit Health keeps growing, even as it loses money

Biotech stock slump in 2023: awaiting the turnaround

leisure time

explore

Wikipedia

hotspot